With energy tensions, shifting rate expectations and mixed growth signals pulling markets in different directions, investors are increasingly looking for companies where earnings are expected to grow solidly and balance sheets are in reasonable shape. That is exactly what the Healthy high growth potential screener is designed to highlight. It focuses on stocks where analysts foresee strong earnings momentum over the next 3 years alongside acceptable financial positions. In this article, you will see 3 of the best stocks from this screener, giving you a clear, practical starting list if you are looking for growth opportunities while keeping an eye on financial quality.
Overview: Aritzia is a Vancouver based fashion company that designs, develops, and sells womens apparel and accessories across its own brands, with products ranging from dresses and denim to activewear and outerwear, sold through boutiques and its online channels in Canada and the United States.
Operations: Aritzia generates all of its CA$4.0b revenue from apparel, with around CA$1.5b coming from Canada and CA$2.5b from the United States.
Market Cap: CA$15.4b
Investors looking at Aritzia are seeing a fashion platform with strong U.S. momentum, where revenue recently reached CA$951.0m in a quarter and net income came in at CA$117.3m, alongside expanding gross and EBITDA margins. Earnings growth has been robust over several years. At the same time, the company carries a premium valuation multiple, relies on higher risk external borrowing and is leaning heavily on U.S. expansion and marketing spend, which leaves little room for disappointment if new stores or consumer demand fall short of expectations.
Aritzia’s accelerating U.S. footprint and premium pricing hint at a bigger story that many investors may be missing. The analyst forecasts for Aritzia could show how tightly that expansion is priced in or where expectations might crack
Overview: Kraken Robotics is a marine technology company that designs and sells sonar and optical sensors, deep sea batteries and underwater robotic systems used by defense forces and offshore energy operators to inspect, map and monitor the seabed and critical underwater infrastructure.
Operations: Kraken Robotics generates around CA$66.3m from Products and CA$41.4m from Services, with sales spread across Asia Pacific, North America and Europe, the Middle East and Africa.
Market Cap: CA$1.9b
Kraken Robotics sits at the intersection of defense modernization and offshore energy investment, supplying high resolution SAS and KATFISH systems, SeaPower batteries and survey services that are seeing fresh contract momentum, including CA$35m of new orders in Q2 2026 and higher 2026 revenue guidance after closing the Covelya acquisition. Analysts expect strong revenue and earnings growth over the next few years as defense and offshore customers adopt more unmanned systems, yet the company is still working its way to consistent profitability, carries meaningful external borrowing and needs to execute on large, lumpy contracts. For investors, the central consideration is how this combination of growth, risk and acquisition activity is reflected in the company’s financials and what that implies for valuation and potential future returns.
Kraken Robotics looks like a growing undersea supplier whose contract momentum and acquisitions could be masking both upside and pressure points. The analyst forecasts for Kraken Robotics might reveal where expectations and reality could suddenly part ways.
Overview: Cameco is a Saskatoon based uranium and nuclear services company that supplies uranium concentrate, fuel services and nuclear reactor technology through its Uranium, Fuel Services and Westinghouse segments to utilities across the Americas, Europe and Asia.
Operations: Cameco generates about CA$3.0b from Uranium, CA$561.4m from Fuel Services and CA$3.6b from Westinghouse, with smaller segment and unallocated adjustments.
Market Cap: CA$53.9b
Cameco gives you direct exposure to the nuclear power chain, from Tier 1 uranium mines like Cigar Lake to Westinghouse’s reactor technology and services. The trade off is a rich valuation, heavy reliance on higher risk external funding and real operational swing factors such as production interruptions, cost inflation and the timing of long term contracting and new reactor decisions. For investors who can handle those swings, the combination of premium pricing, long life assets and a deep project pipeline could be more attractive than it first appears.
Cameco’s premium pricing and long life nuclear assets could be telling a very different story than its headline valuation suggests. The analyst forecasts for Cameco may highlight where expectations and real project risk quietly diverge.
The 3 stocks in this article are just a starting point, and the Healthy high growth potential screen on Simply Wall St surfaced 60 more companies with equally compelling earnings and balance sheet stories through the Healthy high growth potential screener. Use Simply Wall St to identify, filter and analyze the specific catalysts and narratives that matter to you so you can focus on the highest conviction ideas.
If Cameco or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
New breakout ideas do not stay under the radar for long, and the best setups can be caught or missed in a single move, so act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com